Skip to main content
IC
Dianthus Therapeutics, Inc. (DNTH)
NASDAQ: DNTH · Real-Time Price · USD
20.08
+0.49 (2.50%)
At close: May 12, 2025, 4:00 PM
19.41
-0.67 (-3.34%)
After-hours: May 12, 2025, 6:12 PM EDT

Dianthus Therapeutics Revenue

Dianthus Therapeutics had revenue of $1.16M in the quarter ending March 31, 2025, with 33.07% growth. This brings the company's revenue in the last twelve months to $6.52M, up 102.36% year-over-year. In the year 2024, Dianthus Therapeutics had annual revenue of $6.24M with 120.63% growth.

Revenue (ttm)
$6.52M
Revenue Growth
+102.36%
P/S Ratio
107.29
Revenue / Employee
$83,641
Employees
78
Market Cap
645.09M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20246.24M3.41M120.63%
Dec 31, 20232.83M-3.59M-55.96%
Dec 31, 20226.42M4.94M334.76%
Dec 31, 20211.48M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

DNTH News

More News